Increased estimates on higher oil price assumptions Exciting exploration activities ahead P/NAV of 0...
Carlsquare Equity Research presenterar sina första intryck av Enrads kv1 2024-rapport.
Redeye raises its Base Case and forecasts somewhat following a solid Q1 report, beating our expectat...
Redeye reduces its Base Case slightly despite cutting its 2024-2025 EBIT forecasts following a soft ...
Q1 a seasonally small quarter, adj. EBITA of EUR -4m Margin lift from Q2e following recent divestmen...
Highest order intake in company's history We lift '24e-'26e EBIT by 14% on higher sales and GMs EBIT...
Through the completion of the equity issue, Lytix receives NOK50m before transaction costs.
- Gross margin est. down on continually elevated freight rates - '24e-'26e EBITA down 4-2% - '24e-'2...
AcuCort har publicerat bolagets delårsrapport för det första kvartalet 2024.
Redeye comments on Thunderful Group’s divestment of the distribution company of gaming hardware, cal...
Net sales was 3% above Nordea’s estimate in Q1. The company’s EBITDA was EUR 4.
Redeye returns with a research update on Alzecure following its Q1 report and recent events in the c...
Redeye leaves a comment following today’s announcement of a rights issue of approximately SEK34.
DT’s Q1 didn’t contain many surprises other than MBU being weaker and SBU stronger than expected.
Hyresmarknaden förbättrades under kvartalet, vilket spelar Fastpartner rakt i händerna.
Exel’s Q1 results remained quite weak, although q/q improvement continued.
Non-residential volumes supported the profitability in Q1/24 as we had expected.
Redeye comments on yesterday’s news where Tessin has secured additional funding by issuing a convert...
Redeye provides its initial take on Nanologica's Q1 report, which came in largely as expected.
Redeye states that the report aligns with preannounced figures and is slightly below RRe on net sale...
